➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
AstraZeneca

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Litigation Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Chemo Research, S.L.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-02-28 1 Complaint COUNT I FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 8,147,866 (“the ’866 … a) declare that United States Patent Nos. 8,147,866; 9,655,843; and 9,901,539 are valid; …A), Defendants infringed United States Patent Nos. 8,147,866; 9,655,843; and 9,901,539 by submitting …prior to the expiration of United States Patent Nos. 8,147,866; 9,655,843; and 9,901,539 would constitute…than the expiration date of United States Patent Nos. 8,147,866; 9,655,843; and 9,901,539, including any External link to document
2019-02-28 3 ANDA Form 2019 Date of Expiration of Patent: Patent No. 8,147,866: July 23, 2027 … Patent No. 9,655,843: July 23, 2027 Patent No. 9,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 7/31/19. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 8/1/2021… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG External link to document
2019-08-01 38 Complaint for Patent Infringement (D.I. 1). The Asserted Patents are U.S. Patent Nos. 8,147,866; 9,655,843… asserted patent; (d) All documents evidencing ownership of the patent rights by … i. Each claim of each asserted patent that is allegedly infringed by …and v. For any patent that claims priority to an earlier application,…prior to the date of application for the asserted patent(s); (b) All documents evidencing External link to document
2019-02-28 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,147,866 B2 ;9,655,843 B2 ;9,901,539… 1 March 2019 1:19-cv-00444 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Merck
McKesson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.